These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Late orbital radiotherapy combined with intravenous methylprednisolone in the management of long-lasting active graves' orbitopathy: a case report and literature review. Verrienti M; Gagliardi I; Valente L; Stefanelli A; Borgatti L; Franco E; Galiè M; Bondanelli M; Zatelli MC; Ambrosio MR Endocrine; 2024 Aug; 85(2):576-583. PubMed ID: 38517640 [TBL] [Abstract][Full Text] [Related]
47. Risk Factors for Ocular Surface Irritation Symptoms in Inactive Mild and Moderate-to-Severe Graves' Orbitopathy. Yu Y; Hu YX; Lu MX; Ouyang ZL; Xu MT; Zhao LY; Wang M Ophthalmol Ther; 2024 Apr; 13(4):1015-1024. PubMed ID: 38376797 [TBL] [Abstract][Full Text] [Related]
49. Viral conjunctivitis interfering with the clinical activity score and management of thyroid ophthalmopathy. Boboridis KG; Konstas AG; Krassas GE; Georgiadis NS Orbit; 2006 Mar; 25(1):27-9. PubMed ID: 16527772 [TBL] [Abstract][Full Text] [Related]
50. Evaluation of management of Graves' disease in District General Hospital: achievement of consensus guidelines. Dasgupta S; Savage MW Int J Clin Pract; 2005 Sep; 59(9):1097-100. PubMed ID: 16115188 [TBL] [Abstract][Full Text] [Related]
51. Statins in Graves Orbitopathy: A New Therapeutic Tool. Lanzolla G; Comi S; Cosentino G; Pakdel F; Marinò M Ophthalmic Plast Reconstr Surg; 2023 Dec; 39(6S):S29-S39. PubMed ID: 38054983 [TBL] [Abstract][Full Text] [Related]
53. Efficacy of rituximab in treating steroid-resistant Graves' orbitopathy in active moderate-to-severe and sight-threatening forms: A retrospective observation from China. Zhang Z; Feng X; Guo Y; Kang X; Wang D; Zhang J; Zeng Z; Yuan G Heliyon; 2024 Jun; 10(11):e31932. PubMed ID: 38867959 [TBL] [Abstract][Full Text] [Related]
54. Timing of surgery for Graves' orbitopathy. Meyer DR Ophthalmology; 2007 Feb; 114(2):393; author reply 393.e1-2. PubMed ID: 17270689 [No Abstract] [Full Text] [Related]
55. [Graves' orbitopathy: Current concepts for medical treatment]. Oeverhaus M; Stöhr M; Möller L; Führer D; Eckstein A Laryngorhinootologie; 2023 Mar; 102(3):177-185. PubMed ID: 36858060 [TBL] [Abstract][Full Text] [Related]
56. [Therapy for Graves' ophthalmopathy]. Zheng J; Zhang X; Gong R; Wang J; Tan T Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Oct; 21(5):876-9. PubMed ID: 15553880 [TBL] [Abstract][Full Text] [Related]
57. Graves' ophthalmopathy: state of the art and perspectives. Bartalena L; Wiersinga WM; Pinchera A J Endocrinol Invest; 2004 Mar; 27(3):295-301. PubMed ID: 15165007 [TBL] [Abstract][Full Text] [Related]